NEW YORK (GenomeWeb News) – Gene modification firm Transposagen Biopharmaceuticals said on Friday that it received $4.3 million in grants and investments to further develop its DNA modification technology.

The Lexington, Ky.-based firm said that it received a Small Business Innovation Research grant of almost $2.0 million from the National Institutes of Health's Office of the Director, and a $1.0 million grant from the Kentucky Cabinet for Economic Development.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latinas scientists further had to navigate racial stereotypes.

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.